The Challenge of Assessing Adherence to Subcutaneous Biological Drugs in Immune-Mediated Inflammatory Diseases. Letter to the Editor Regarding Michetti P, Weinman J, Mrowietz U, et al. Adv Ther (2017);34:91–108. doi:10.1007/s12325-016-0441-3
Crossref DOI link: https://doi.org/10.1007/s12325-017-0602-z
Published Online: 2017-08-17
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cea-Calvo, Luis
Carmona, Loreto
Calvo-Alén, Jaime
Text and Data Mining valid from 2017-08-17
Article History
Received: 23 May 2017
First Online: 17 August 2017